In June 2021, the European Commission has proposed Commission Implementing Decision on the identification of resorcinol as a substance of very high concern.

The reason that resorcinol is included in the candidate list is its endocrine disrupting properties, with probable serious effects to human health which give rise to an equivalent level of concern to those of other substances listed in Article 57, points (a) to (e), of the REACH Regulation (EC) No 1907/2006.

The substance resorcinol was proposed by France in February 2020, to be identified as an SVHC. However, ECHA’s Member State Committee (MSC) did not reach unanimous agreement on identifying resorcinol as an SVHC. In July 2020, MSC’s opinion were referred to the European Commission for a decision.

The European Commission has concluded that there is scientific evidence of probable serious effects to human health for resorcinol. In June 2021, the European Commission prepared a draft proposal on the identification as an SVHC. A final decision will be made in its committee procedure.

The substance proposed by the European Commission to be included in SVHC list (Candidate list):